MariMed Inc. (OTC:MRMD – Free Report) – Analysts at Ventum Cap Mkts issued their FY2026 earnings per share estimates for MariMed in a report released on Thursday, November 7th. Ventum Cap Mkts analyst A. Semple anticipates that the company will post earnings per share of $0.00 for the year. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock. The consensus estimate for MariMed’s current full-year earnings is ($0.02) per share.
MariMed Stock Performance
MRMD opened at $0.15 on Monday. The firm has a market capitalization of $55.15 million, a P/E ratio of -4.83 and a beta of 2.80. The stock’s fifty day moving average price is $0.16. MariMed has a fifty-two week low of $0.14 and a fifty-two week high of $0.39. The company has a quick ratio of 0.54, a current ratio of 1.30 and a debt-to-equity ratio of 1.05.
About MariMed
MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.
See Also
- Five stocks we like better than MariMed
- What Is WallStreetBets and What Stocks Are They Targeting?
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- How to Read Stock Charts for Beginners
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
